Many patients with sporadic Alzheimer's disease (AD) suffer from memory impairment,
anxiety-and depression. The systemic utility of N-Methyl-d-Aspartate (NMDA) receptor …

Amyloid beta (Aβ)-mediated synapse dysfunction and spine loss are considered to be early
events in Alzheimer's disease (AD) pathogenesis. N-methyl-D-aspartate receptors …

The prevalence of Alzheimer's disease (AD) in the elderly is growing rapidly worldwide, and
the deteriorating clinical course of AD places a heavy burden on both the patients and their …

Dementia has become an all-important disease because the population is aging rapidly and
the cost of health care associated with dementia is ever increasing. In addition to cognitive …

Abstract N‐methyl‐D‐aspartate (NMDA) receptor hypofunction is associated with a range of
effects on cognition and behavior in whole animal and human studies. NMDA receptor …

The cholinergic system is crucial for cognitive processes and the deficient acetylcholine
(ACh) function has been implicated in Alzheimer's disease (AD). Inhibitors of …

The N-methyl-D-aspartate receptor is a critical molecule for synaptic plasticity and cognitive
function. Impaired synaptic plasticity is thought to contribute to the cognitive impairment …

A redox-mediated decrease in N-methyl-D-aspartate (NMDA) receptor function contributes
to psychiatric diseases and impaired cognition during aging. Inflammation provides a …

Neuroinflammation plays a key role in the initiation and progression of neurodegeneration in
Alzheimer's disease (AD). Chronic neuroinflammation results in diminished synaptic …

Background Neuroinflammation plays a prominent role in the progression of Alzheimer's
disease and may be responsible for degeneration in vulnerable regions such as the …